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Abstract Mutations in the protein DJ-1 cause recessive
forms of early onset familial Parkinson’s disease (PD). To
date, most of the causative mutations studied destabilize
formation of DJ-1 homodimers, which appears to be closely
linked to its normal function in oxidative stress and other
cellular processes. Despite the importance of understanding
the dimerization dynamics of this protein, this aspect of DJ-
1 biology has not previously been directly studied in living
cells. Here, we use bimolecular fluorescence complementa-
tion to study DJ-1 dimerization and find not only that DJ-1
forms homodimers in living cells but that most PD causative
DJ-1 mutations disrupt this process, including the L166P,
M26I, L10P, and P158Δ mutations. Interestingly, the E64D
mutant form of DJ-1 retains the ability to form homodimers.
However, while wild-type DJ-1 dimers are stabilized under
oxidative stress conditions, we find that the E64D mutation
blocks this stabilization. Furthermore, our data show that the
E64D mutation potentiates the formation of aggresomes
containing DJ-1. We also observe that while the widely
studied L166P mutation prevents DJ-1 from forming homo-
dimers or heterodimers with wild-type protein, the mutant
protein is able to partially disrupt formation of wild-type
homodimers. In summary, by investigating DJ-1 dimeriza-
tion in living cells, we have uncovered several novel prop-
erties of PD causative mutations in DJ-1, which may
ultimately provide novel insight into PD pathogenesis and
possible therapeutic options.
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Introduction
Parkinson’s disease (PD) is the second most common neu-
rodegenerative disorder after Alzheimer’s disease. However,
the mechanisms underlying causation and progression of
this disorder are not well understood. While sporadic PD
accounts for more than 90 % of all cases, the study of rare
genetic forms may contribute to our understanding of the
cellular mechanisms underlying the pathogenesis of both
idiopathic and familial forms of the disease. Mutations in
the PARK7 gene account for ~1–2 % of the sporadic cases of
early onset recessive PD [1]. Since 2003, when a large
homozygous deletion and a homozygous missense mutation
in the PARK7 gene were first reported in two European
families, numerous other mutations have been identified
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[2]. Among these, homozygous and compound heterozy-
gous mutations are clearly associated with early onset PD,
while it is unclear if heterozygous mutations are PD causative
[3].
PARK7-related PD symptomatology is characterized by
levodopa-responsive parkinsonism with an early age at on-
set and generally no atypical signs. PARK7 encodes for DJ-
1, a small conserved protein of 189 amino acids (aa), which
is not only ubiquitously expressed and primarily localized to
the cytoplasm but also found in the nucleus and associated
with mitochondria [4–7]. Structural studies have shown that
the monomeric form of DJ-1 contains a conserved α/β
sandwich fold found in members of the ThiJ/PfpI protein
superfamily [8, 9] and that, at least in vitro, DJ-1 exists as
homodimer, which appears to be critical for its normal
physiological function [10, 11].
DJ-1 has been implicated in several pathways associated
with PD pathogenesis, but the exact molecular mechanisms
underlying its contribution to disease are still elusive. None-
theless, it is clear that this protein plays an important role in
cellular response to oxidative stress and is required for
mitochondrial health [12, 13]. Despite the rare incidence
of DJ-1 mutations in PD, the study of DJ-1 biology can
provide important clues to altered cellular pathways in PD.
Thus, understanding how the causative DJ-1 mutations in-
terfere with the structure, function, and localization of DJ-1
protein is of critical importance.
The L166P mutation [5] severely perturbs DJ-1 protein
structure, resulting in the formation of a spontaneously
unfolded protein [14]. Furthermore, using biochemical
approaches, it was found that the L166P mutant protein
does not dimerize [8, 14] and is extremely unstable when
expressed in mammalian cell lines [14–18]. In comparison,
little is known about the effect of other DJ-1 mutations on its
structure/function. The expression levels of the M26I mu-
tant are decreased in cell lines, though to a lesser degree than
the L166P mutant, and the M26I protein may retain the
ability to dimerize [4, 19]. However, the M26I homodimer
is less stable than the wild-type dimer [20]. Two additional
causative DJ-1 mutations—L10P and P158Δ—are charac-
terized by decreased stability and impaired homodimer for-
mation [21]. Interestingly, the crystal structure of the E64D
mutant protein is not altered [22], and this mutant protein is
stable in cells and can dimerize in manner similar to WT DJ-
1 [15, 20]. Thus, the studies to date shed little light on how
the E64D mutation is causative in PD and suggest a func-
tional divergence in the nature of the disease-causing DJ-1
mutations.
Here, we take advantage of bimolecular fluorescence
complementation (BiFC) to elucidate DJ-1 function in liv-
ing cells and study a panel of DJ-1 mutations (L166P, E64D,
M26I, L10P, and P158Δ). To date, only biochemical
approaches have been used to analyze DJ-1 dimerization,
providing little insight into the dynamics of this process in
cells. Importantly, we demonstrate that BiFC is a powerful
tool for the study of DJ-1 dimerization in living cells. We
also find that—uniquely among the mutant proteins studied
—the E64D mutation does not impair dimer formation in
normal conditions but does alter dimerization dynamics
under oxidative stress conditions. Furthermore, we find that
the E64D dimers show an increased propensity to form
aggresomes in living cells, which may have implications
for its role in pathogenesis. In summary, our study finds that
dimerization of DJ-1 in living cells is an exquisitely sensi-
tive process and uncovers novel aspects of the role causative
mutations play in DJ-1 dysfunction, which may open novel
avenues for therapeutic intervention in PD.
Materials and methods
Generation of DJ-1 constructs
The two WT DJ-1 BiFC constructs (DJ1-GN173 and DJ1-
CC155) were generated by PCR-based cloning into
pcDNA3.1 vector. The constructs encoding five mutant
forms of DJ-1 (L166P, M26I, P158Δ, L10P, and E64D)
were produced via a combination of the Stratagene Quik-
change II XL and Phusion Site-Directed Mutagenesis (F-
541, Finnzymes) methods, using both WT DJ1-GN173 and
WT DJ1-CC155 as templates. The primer pairs used are
listed in Table S1. All constructs were verified by DNA
sequencing.
Cell culture and transient transfection techniques
HEK 293T cells were plated on 35-mm ibiTreat dishes
(IBIDI) at the density of 1×105 cells/dish for confocal laser
scanning microscope (CLSM) analysis in living cells, or in
six-well plates (1.5×105 cells/well) precoated with 0.01 %
poly-L-lysine solution for BiFC experiments, and cultured in
Dulbecco’s modified Eagle’s medium, high glucose, supple-
mented with 10 % fetal bovine serum, 100 U/ml penicillin,
and 100 μg/ml streptomycin, at 37 °C in a 95 % air/5 % CO2
atmosphere. Cells were plated on coverslips precoated with
0.01 % poly-L-lysine solution for immunocytochemistry
studies. Transfection was performed 24 h after plating using
the Effectene Transfection Reagent kit (Qiagen) using pro-
cedures supplied by the manufacturer. The percentage trans-
fection efficiency was routinely >50 %. Cells were lysed
either 24 or 48 h after transfection for immunoblotting
studies. For oxidative stress treatments, cells were exposed
24 h after transfection to either paraquat 200 μM for 24 h or
to hydrogen peroxide 1 mM for 2 h. After the treatment,
cells were washed with phosphate-buffered saline (PBS),
and fresh medium was added before BiFC analysis.
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Fluorescence complementation assay and live cell imaging
Cells were imaged 24 or 48 h posttransfection on an Olympus
ScanˆR screening station equipped with a 20× LUCPlanFLN
objective (NA00.45) and a Hamamatsu ORCA-AG CCD cam-
era. The light source was a MT-20 illumination system (Olym-
pus Biosystems) with a high-stability 150 W xenon arc burner.
During imaging, the cells were kept at 37 °C and 5 % CO2.
Green fluorescent protein (GFP) BiFC fluorescence was
detected using a 492/18 nm excitation filter and 535/50 nm
emission filter. To detect transfected cells and to compare the
efficiencies of fluorescence complementation betweenwild-type
and mutant DJ-1 proteins, HEK 293T cells were cotransfected
with the pcDNA3.1 plasmid-expressing red fluorescent protein
(RFP). RFP expression was imaged using excitation at 556/
30 nm and emission between 590 and 650 nm using the filterset
51019 (Chroma). The ratio between GFP and RFP emissions
was quantified for every cell expressing RFP after subtraction of
the background signal, 100 pictures were taken per well in each
experiment. Typically, several hundred cells were identified and
quantified for each condition in each independent experiment
and analyzed using the ScanˆR analysis software.
Immunocytochemistry and confocal laser scanner
microscopy analysis
Twenty-four or 48 h after transfection, cells were fixed in
4 % paraformaldheyde in PBS for 20 min at 37 °C and then
incubated in 1 % bovine serum albumin (BSA) in PBS
0.2 % Triton for 30 min at room temperature. Primary anti-
bodies were diluted 1:200 (anti-DJ-1, sc-27006, Santa Cruz
Biotechnology), 1:100 (anti-DJ-1, sc-55572, Santa Cruz
Biotechnology), 1:1,000 (anti GFP, ab6556 Abcam), 1:200
(anti-HtrA2, AF1458, R&D Systems), 1:100 (anti-Vimen-
tin, 5741, Cell Signalling Technology), in blocking solution
and incubated overnight at 4 °C. After washing in PBS, cells
were incubated for 2 min in 1:2,000 Hoechst 33342 trihy-
drocloride, 10 mg/ml solution (Invitrogen), in PBS. Second-
ary antibodies were diluted 1:500 (Alexa Fluor 546 antigoat
and anti rabbit) in PBS 0.2 % Triton+1 % BSA and incu-
bated at room temperature for 1 h. Finally, cells were rinsed
in PBS, and coverslips were mounted in Mowiol.
CLSM analysis was performed using an Olympus
FV1000 confocal laser scanning microscope. Cells were
imaged in sequential mode using a 60× UPlanSAPO Olym-
pus objective, Kalman filter of 4, and a zoom of 1.5. The
following settings were used: for Hoechst, excitation of
405 nm laser line, emission detected between 425 and
475 nm; for GFP BiFC, excitation of 488 nm laser line,
emission detected between 500 and 545 nm; for RFP/Alexa
546, excitation of 559 nm laser line, emission 575–675 nm;
and for Alexa 647, excitation of 635 nm laser line and
emission of 655–755 nm.
Immunoblotting
Cells were washed twice with sterile PBS and then lysed on
ice for 10 min in lysis buffer [23]. Lysates were centrifuged
at 13,000 rpm for 10 min at 4 °C. Supernatants were col-
lected, and protein concentration was determined by the
Bradford method. Samples were stored at−80 °C until used.
Proteins were separated on a 10 % SDS polyacrylamide gel
(10 μg of total proteins per well) and transferred to a poly-
vinylidene difluoride membrane. Membranes were incubat-
ed for 1 h in TBST 5 % milk to saturate all non-specific
binding sites (blocking solution). Incubation with primary
antibodies was overnight at 4 °C, using goat anti-DJ-1
antibody (1:2,000; sc-27006, Santa Cruz Biotechnology)
or mouse anti-tubulin (1:1,000; sc-8035, Santa Cruz Bio-
technology). Blots were developed using horseradish
peroxidase-conjugated secondary antibodies (1:10,000; PI-
9500 horse antigoat Vector Laboratories and 1:80,000;
31430 goat antimouse Thermo Scientific Pierce) and the
ECL chemiluminescence system (SuperSignal West Dura
Extended Duration Substrate, Thermo Scientific).
Aggresome quantification
HEK 293T cells were transfected with either the two WT
DJ-1 or the two E64D DJ-1 BiFC constructs, fixed 48 h after
transfection, subjected to Hoechst 33342 trihydrocloride
staining and analyzed for aggresome formation. An aggre-
some was defined as a single, BiFC positive, perinuclear
inclusion. For each experiment, 50 pictures per well were
taken randomly, and DAPI-positive cells were counted and
evaluated for the presence of aggresomes in a blinded man-
ner. Experiments were repeated three times, and an un-
paired, two-tailed t test was used to assess statistical
significance (data0mean ± SEM; P00.0018).
Molecular dynamics simulations and structural analysis
Molecular dynamics simulations in solvated media were per-
formed with the GROMACS 4 package using the all-atom
GROMOS96 forcefield. Coordinates of the DJ-1 wild-type
proteins for the simulations were obtained from the PDB
database (PDB codes: 1PF5 for the DJ-1 monomer, and
1SOA for the dimer). Mutants were manually built by replac-
ing the selected residues in the coordinates using Coot soft-
ware [24]. All the simulations were started with the native
conformations of the peptides with a protonation of side
chains consistent with a pH07. Proteins were solvated in a
water box of 100×100×100 Å and a density of 1 g/cm3. The
solvated models were energy minimized by conjugated gra-
dient for 1,000 steps to eliminate steric clashes between atoms.
All the systems were equilibrated by simulated annealing with
slow temperature decreasing from 2,500 to 300 K over 1,000
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cycles. Molecular dynamics simulations were then performed
over 1,000 ps at 300 K and data collected every 1 ps. All the
molecular representations depicted in the figures were built
using Pymol. Calculation of continuous molecular surface
properties was performed using VASCo software [25]. Polar
patches on the protein surfaces were located by using Hot-
Patch software [26].
Statistical analysis
BiFC data were analyzed with Prism 5 (GraphPad), using the
Kruskal–Wallis test followed by post hoc analysis with a
Dunn test. P<0.05 is considered significant for any set of
data. In all experiments, results are expressed as means±SEM.
Results
The L166P mutation prevents dimerization of DJ-1 in living
human cells
The ability of DJ-1 to form dimers in living cells was inves-
tigated using BiFC, which utilizes the reconstitution of non-
fluorescent fragments of GFP to study protein–protein
interactions [27]. We hypothesized that if DJ-1 dimerizes in
living cells the two nonfluorescent fragments would be
brought together, reassociate, and refold into a fluorescent
complex. To explore this possibility, we generated two wild-
type (WT) DJ-1 BiFC constructs (DJ-1-GN173 and DJ-1-
CC155) predicted to generate a fluorescent complex upon
DJ-1 dimerization (Fig. 1a). DJ-1-GN173 contains the N-
terminal 173 amino acid (aa) residues of GFP connected by
a polylinker to the C terminus of full-length DJ-1. On the other
hand, DJ-1-CC155 comprises a C-terminal fragment of CFP
(155–238 aa) fused to the C terminus of full-length DJ-1 via a
polylinker region. We used CFP to complement GFP, as this
combination allows for a better fluorescent complementation
signal compared to the one obtained with the C terminus of
GFP [28]. These constructs were transfected into HEK 293T
cells individually or together and incubated for 24 h at either
30 or 37 °C—the lower temperature allowing for better mat-
uration of the fluorophore [29]. No fluorescent signal was
detected when cells were transfected with only one WT DJ-
1 BiFC construct at either temperature (Fig. S1a), whereas the
cotransfection of both constructs resulted in the formation of
fluorescent signal (Fig. 1b) that was enhanced by incubation at
30 °C (Fig. S1b). Analysis of optical sections obtained using a
CLSM revealed both cytoplasmic and nuclear localization of
DJ-1. Thus, our experiments in living cells indicate that DJ-1
dimerizes, validating previous biochemical observations.
To further validate BiFC as a system for the study of DJ-1
dimerization, we next tested DJ-1 carrying the L166P muta-
tion, which has been shown to completely abrogate function
of this protein [16, 17]. When we analyzed the signal obtained
from expression of the two L166P DJ-1 BiFC constructs, we
found that the L166P mutation virtually eliminated fluores-
cence complementation in HEK 293T cells (Fig. 1b). To
quantify the effects of the L166P mutation on dimerization
Fig. 1 DJ-1 forms dimers in living cells. a Schematic representation of
the BiFC constructs used. DJ-1-GN173 contains a polylinker region
linking the 172 N-terminal amino acid residues of the GFP attached to
the C terminus of full-length DJ-1. DJ-1-CC155 contains the 155–238
C-terminal residues of CFP linked via a polylinker region to the C
terminus of full-length DJ-1. b One optical section taken on a confocal
laser scanning microscope showing the complementation reaction
driven by DJ-1 dimerization in living HEK293T cells. Both cytoplas-
mic and nuclear signal were observed in cells transfected with WT DJ-
1 BiFC constructs. The L166P mutation completely prevents DJ-1
dimerization. HEK 293T cells were cotransfected with the pcDNA3.1
plasmid expressing RFP to allow for normalization of the BiFC signal.
Scale bar010 μm
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Fig. 2 Effect of the L166P mutation on the efficiency of fluorescence
complementation between DJ-1 BiFC constructs 24 h after transfection in
HEK 293T cells. a. The distribution of ratios between GFP and RFP
emissions in individual cells cotransfected with plasmids encoding the
proteins is indicated in each graph. Emission intensities were corrected
for background fluorescence using the ScanˆR analysis software. 0.16 μg
of each of the DJ-1 BiFC constructs and 0.08 μg of the RFP encoding
plasmid were used. The histogram (c) shows the average ratio intensity
(green/red) per well: No difference was observed in the complementation
signal between the two L166P DJ-1 BiFC contructs and both combinations
of WT DJ-1 and L166P mutant DJ-1 GFP halves, indicating that L166P
DJ-1 is not able to dimerize with WT DJ-1. Data are expressed as mean ±
SEM. e Anti DJ-1 immunoblots of the lysates obtained from transfected
cell populations used in this BiFC experiment show the expression levels of
the different BiFC constructs, compared to endogenous DJ-1 and to the
loading control. In each lane, the upper band corresponds to DJ-1-GN173
and the intermediate band corresponds to DJ-1-CC155. b Effect of L166P
mutation on the efficiency of fluorescence complementation between DJ-1
constructs, when BiFC constructs are normalized for protein levels. The
amount of plasmids encoding the BiFC constructs used was: 0.1 μg for the
two WT DJ-1 constructs; 0.21 μg for the two L166P DJ-1 constructs, and
0.1 μgWTDJ-1+0.21 μg L166P DJ-1 for both combinations of WT DJ-1
and L166Pmutant DJ-1 GFP halves; 0.08 μg of the plasmid encoding RFP
were used in each condition. dAverage ratio intensity per well of the BiFC
experiment shown in b. f Immunoblots of the lysates obtained from the
transfected cell populations used in b. ***P<0.001
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efficiency, we normalized the GFP emissions by the emissions
of RFP produced from a cotransfected expression plasmid (see
“Materials and methods”) (Fig. 2a, c). Supporting and extend-
ing previous biochemical analyses, we found that L166P
strongly reduced BiFC signal, clearly indicating that this
mutation prevents DJ-1 dimerization in living cells.
Immunoblotting analysis using the DJ-1 antibody
revealed the presence of exogenous proteins with the
expected molecular weights (DJ1-GN173 at ~45 kDa; and
DJ1-CC155 at ~33 kDa), as well as endogenous DJ-1
(Fig. 2e). We found that expression levels of the WT DJ-1
BiFC constructs were comparable to endogenous DJ-1 lev-
els and that the L166P mutation caused a decrease in the
expression levels of the BiFC constructs compared to the
WT DJ-1 BiFC constructs. To ascertain if the observed
effect on fluorescence was entirely dependent on protein
levels and not dimerization per se, we normalized L166P
protein levels by transfecting the cells with increased DNA
concentrations of the BiFC constructs (Fig. 2f and data not
shown). BiFC experiments repeated under these conditions
showed that, in addition to reducing protein levels, the
L166P mutation also directly reduces the ability of DJ-1 to
dimerize (Fig. 2b, d). Indeed, we observed no L166P DJ-1
fluorescence complementation signal despite an increased
level of L166P DJ-1-GN173 protein relative to WT (Fig. 2f).
To gain insight into DJ-1 dimerization for individuals
heterozygous for the L166P DJ-1 mutation, we next used
BiFC to test the dimerization capacity of DJ-1 heterodimers.
HEK 293T cells were transfected with both combinations of
WT DJ-1 and L166P mutant DJ-1 GFP halves. A very low
fluorescence ratio, comparable to the one obtained with the
two L166P-DJ-1 constructs, was observed for both condi-
tions, suggesting that L166P DJ-1 is not able to significantly
dimerize with WT DJ-1 (Fig. 2c, d).
As heterozygous individuals are predicted to still exhibit
dimers of WT DJ-1, we chose to explore the potential of
L166P DJ-1 to disrupt such dimers via competition experi-
ments. We first determined that we could competitively
reduce the amount of fluorescent signal by introducing a
“cold” nontagged DJ-1 construct (Fig. S2). Having validat-
ed this approach, we then investigated whether the L166P
mutant could affect WT DJ-1 dimerization efficiency. Cells
were transfected with both WT DJ-1 constructs along with
either the L166P DJ1-GN173 or the L166P DJ1-CC155
construct, thus creating competition for WT homodimer
formation by L166P DJ-1. A significant reduction in fluo-
rescence complementation was observed with either L166P
construct (Fig. 3a, b), indicating that less dimer forms in the
presence of this DJ-1 mutant protein. This suggests for the
first time that, in addition to causing loss of normal DJ-1
function, the L166P mutation may generate a mutant form
of DJ-1, which exhibits a negative effect on WT DJ-1
present in the cell.
The E64D mutant does not abrogate DJ-1 dimerization
in living cells
Next, we generated E64D, M26I, L10P, and P158Δ mutant
versions of the DJ-1 BiFC constructs by site-directed muta-
genesis and used the BiFC assay to investigate dimerization
dynamics of these mutants in living cells. Cells expressing
Fig. 3 L166P DJ-1 disrupts formation of WT DJ-1 dimers. a Distri-
bution of ratios between GFP and RFP emissions in individual cells.
0.16 μg of each of the DJ-1 BiFC constructs and 0.08 μg of the RFP
encoding plasmid were used. b Average ratio intensity (green/red) per
well. *P<0.05; ***P<0.001
604 J Mol Med (2013) 91:599–611
the M26I, L10P, or P158Δ mutant BiFC constructs
exhibited a very low complementation signal—not
significantly different than the L166P mutant—indicating
that these DJ-1 mutants are unable to form dimers in living
Fig. 4 Effect of M26I, P158Δ, L10P and E64D mutations on the
efficiency of fluorescence complementation between DJ-1 BiFC con-
structs. a BiFC signal under “homozygous conditions” for M26I,
P158Δ, L10P, and E64D DJ-1 mutants. The distribution of ratios
between GFP and RFP emissions in individual cells co-transfected
with plasmids encoding the proteins indicated in each graph (0.16 μg
each) and plasmid encoding RFP (0.08 μg) is shown. Emission inten-
sities were corrected for background fluorescence. The histogram
shows the average ratio intensity (green/red) per well for each exper-
iment. ***P<0.001. b BiFC signal under “heterozygous conditions”
for the P158Δ, E64D, and L10P DJ-1 mutants. While the P158Δ
mutant dimerizes with the WT protein at a reduced level and the
L10P mutant is not able to dimerize with WT DJ-1, the E64D mutant
completely retains its dimerization ability (no significant difference
compared to the WT DJ-1 BiFC signal). ***P<0.001
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cells (Fig. 4a). Furthermore, immunoblotting analysis
experiments detected a lower level of these mutant proteins
compared to WT DJ-1, suggesting that the mutant proteins
are rapidly degraded in living cells (data not shown). On the
other hand, when HEK 293T cells were transfected with
E64D mutant DJ-1 GFP halves, a fluorescence ratio com-
parable to the one obtained with the WT DJ-1 constructs
was observed, indicating that E64D DJ-1 is able to dimerize
in living cells (Fig. 4a). The level of E64D DJ-1 protein was
comparable to WT DJ-1 control constructs, and analysis by
CLSM showed a similar cytoplasmic and nuclear localiza-
tion pattern as WT DJ-1 constructs (data not shown). Final-
ly, we tested the ability of the L10P, P158Δ, and E64D
mutants to form heterodimers with WT DJ-1. Interestingly,
while L10P DJ-1 is not able to dimerize with the WT
protein, an intermediate level of complementation was
obtained for the P158Δ/WT DJ-1 heterodimer (Fig. 4b).
On the other hand, no change in the BiFC signal was
observed for E64D/WT DJ-1 heterodimers (Fig. 4b), further
underscoring that E64D DJ-1 does not exhibit impaired
dimerization under normal conditions.
WT DJ-1 dimers, but not E64D DJ-1 dimers, are stabilized
under oxidative stress conditions
As DJ-1 plays an important role in cellular protection from
oxidative stress [6, 30, 31], we next used BiFC to test the
effect of oxidant treatments on the dimerization of WT and
E64D DJ-1. We found that treatment with either paraquat or
hydrogen peroxide increased BiFC fluorescence for WT DJ-1
(Fig. 5), indicating a stabilization of dimerization under oxi-
dative stress conditions. Interestingly, we did not observe this
increase with E64D DJ-1 BiFC signal. Indeed, the fluorescent
signal for the E64D DJ-1 dimer was decreased in the case of
the paraquat treatment (Fig. 5a) and unchanged with hydrogen
peroxide treatment (Fig. 5b). These data suggest that, though
E64D mutant retains its dimerization ability, it does not be-
have like WT DJ-1 under oxidative stress conditions, which
may have implications for its role in PD pathogenesis.
E64D DJ-1 dimers form cytoplasmic inclusions in living
cells
We next examined the dimerization signal obtained in cells
transfected with WT and E64D DJ-1 by CLSM. Time course
experiments revealed that BiFC complementation could be
observed as early as 18 h posttransfection at 37 °C and that the
brightest signal was obtained 36–48 h posttransfection for
both WT and E64D DJ-1 constructs (data not shown). Anal-
ysis of the BiFC signal at 24 h posttransfection—the time
point used for the BiFC experiments—showed that DJ-1
dimer localizes primarily to the cytoplasm, but is also found
in the nucleus under control conditions (Fig. 6a). In agreement
with the BiFC signal, immunocytochemistry (ICC) using GFP
antibodies clearly labels transfected cells, while ICC using DJ-
1 antibodies detected expression of DJ-1 in both transfected
(brighter) and untransfected (weaker) cells, indicating the
presence of endogenous DJ-1. No difference in subcellular
localization was observed between DJ-1 dimer and endoge-
nous DJ-1. The complementation signal 48 h after transfection
was brighter for both WT and E64D BiFC constructs, and
intracellular inclusion bodies containing DJ-1 dimers were
detected in both WT and E64D DJ-1 transfected cells
(Fig. S3). Provocatively, we found that the number of cells
with inclusions was increased by ~75 % in cells expressing
E64DDJ-1 versusWTDJ-1, indicating a specific effect of the
E64D mutant on DJ-1 aggregation (Fig. 6b).
Fig. 5 Oxidative stress stabilizes WT DJ-1 dimerization. HEK 293T
cells were transfected with either two WT, L166P, or E64D DJ-1 BiFC
constructs (0.16 μg of each BiFC plasmid and 0.08 μg of the RFP
encoding plasmid) for 24 h and then subjected to oxidative stress by
exposure to either a 200 μM paraquat for 24 h or b 1 mM hydrogen
peroxide for 2 h. BiFC imaging was performed in normal medium
immediately after the oxidative stress treatment. The histogram shows
the average ratio intensity (green/red) per well ± SEM. ***P<0.001
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Fig. 6 E64D DJ-1 forms cytoplasmic inclusions in living cells. a
CLSM analysis of WT DJ-1 BiFC signal 24 h after transfection in
HEK 293T cells after fixation and double labelling with both anti GFP
and anti DJ-1 antibody. ICC experiments confirm the immunopositiv-
ity of WT DJ-1 transfected cells for both GFP and DJ-1. The anti DJ-1
antibody also detected endogenous DJ-1. Scale bar020 μm. b
Percentage of WT and E64D cells containing aggresomes 48 h after
transfection. **P<0.01. c HEK 293T cells transfected with the two
E64D DJ-1 BiFC constructs were fixed 48 h after transfection and
subjected to immunostaining for the mitochondrial marker HtrA2/Omi,
DJ-1, and the intermediate filament protein Vimentin. Scale bar0
10 μm
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We then characterized these cytoplasmic inclusions by
immunocytochemical studies and CLSM (Fig. 6c). We found
that the E64D DJ-1 inclusions are recognized by an anti-DJ-1
antibody and have perinuclear localization. Furthermore, mi-
tochondria are not localized within the inclusions, as shown
by immunolabeling with the mitochondrial marker Htra2/
Omi. Finally, we found that vimentin, an established marker
for aggresomes, is recruited to the DJ-1 aggregates. Thus,
these data suggest that E64DDJ-1 has an increased propensity
to form aggresomes in living cells, which may have relevance
to the mechanism(s) underlying pathogenesis of this mutation.
E64D dimers show a distinct pattern of surface charge
distribution
In order to further characterize the molecular properties of
the E64D DJ-1 mutant, we performed molecular dynamics
simulations (MD) of the dimeric protein variants in aqueous
media within a time interval of 1,000 ps. Despite E64D
localization at the surface of the molecule on the DJ-1
crystal structure, MD simulation data analysis clearly
showed a strong influence of the mutation in the hydrody-
namic properties of dimeric DJ-1 during the simulation
(Fig. 7). Indeed, the total exposed surface area and the
radius of gyration increased in the E64D mutant during the
simulation in comparison with WT DJ-1 (Fig. 7a, b). Also
evident are the molecular movements of the protein back-
bone as quantified by the global and atomic root mean
square deviations (RMSD) (Fig. 7c, d). The E64D mutant
showed an increased global RMSD value in the simulation,
which demonstrated an increase in the vibrational entropy of
the protein chain. Moreover, some regions within the protein
backbone appeared to be more sensitive in E64D DJ-1, as
calculated by the individual RMSD for C-alpha atoms
(Fig. 7d). In particular, the E64D mutation leads to an
increase in RMSD values for residues 30 to 60 in both of
the monomeric components.
Interestingly, the observed molecular differences between
WT and E64D DJ-1 were not restricted to the hydrodynamic
properties of the proteins. Indeed, the distribution of electro-
static patches over the surface of both species at the end ofMD
simulation appears quite different (Fig. 7e, f). The The E64D
mutant contains a highly positive exposed surface patch in the
equatorial region of the dimer, which is not present in the
wild-type protein (Fig. 7f). These observed differences in the
hydrodynamic and electrostatic properties could suggest a
basis for the differential behaviour of the mutant and wild-
type proteins regarding aggregation propensity.
Discussion
The determination of the DJ-1 protein structure [8, 9] first
indicated that dimer formation was a stable and conserved
oligomerization state for this protein. This has since been
confirmed by biochemical approaches in vitro [4, 6, 10],
Fig. 7 Analysis of the molecular dynamics trajectories obtained from
the wild-type and E64D DJ-1 dimers during a 1,000-ps simulation in
aqueous solution. a Exposed total surface area. b Radius of gyration. c
Root mean square deviation values for the complete polypeptide chain
along the simulation. d Root mean square deviation values for the
atomic positions of C-alpha carbons in both species at the end of the
simulation using as a reference the initial atomic coordinates in each
model. e, f Representation of surface charged patches on the surface of
WT and E64D DJ-1 dimer variants as calculated by Hotpatch software
at the end of the MD simulation. e Negatively charged patches and f
positively charged patches. Molecules are represented in two orienta-
tions obtained by a 180° equatorial turn
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suggesting that mutations responsible for dimer disrup-
tion cause a loss of function of DJ-1 activity. This
hypothesis agrees with the recessive nature of DJ-1
associated PD, although to date DJ-1 protein function
remains poorly understood. In the present study, we find
that WT DJ-1 readily dimerizes in living cells, and this
is completely prevented by the L166P mutation, in
agreement with previous biochemical data [4, 10, 14,
16, 18], as well as structural and MD studies [19, 32].
Strikingly, using BiFC, we found that while the L166P
DJ-1 mutant cannot dimerize with the WT protein, it
can negatively impact the formation of WT DJ-1
dimers.
Despite the fact that both L166P and M26I mutations are
localized to the dimer interface, previous studies investigat-
ing M26I DJ-1 dimerization are controversial. Some authors
report M26I retains dimerization ability [4, 18, 33, 34],
while other studies found decreased dimerization of the
M26I mutant [20] and high protein destabilization resulting
in a strongly reduced levels of M26I DJ-1 protein [35]. Our
dimerization data support these latter results, which indicate
that in living cells M26I mutant behaves like the L166P DJ-
1 mutant. In our studies, this appears to be primarily due to a
very low level of the M26I protein 24 h after transfection. In
addition, our studies in living cells corroborate biochemical
data on two more recently identified DJ-1 causative muta-
tions—L10P and P158Δ [21]. Neither of these mutants is
able to form homodimers, likely again as a consequence of
the very low level of the mutant protein observed at the time
of BiFC imaging.
A completely different picture has emerged for the E64D
DJ-1 mutant based on previous in vitro studies, where
normal dimerization has been observed by biochemical
approaches [15, 19, 20]. In the present study, we were able
to validate this result in living cells, finding no difference in
dimerization between this mutant and WT protein. Despite
normal dimerization, E64D DJ-1 has a decreased ability to
prevent dopaminergic neurotoxicity elicited by different
toxic stimuli in primary midbrain cultures [36], and human
fibroblasts from homozygous carriers of the E64D mutation
have reduced mitochondrial branching, a phenotype similar
to that observed in murine embryonic fibroblasts from DJ-1
knockout mice [37]. Thus, understanding how the E64D
mutation is causative in PD is a very intriguing aspect of
DJ-1 biology.
Here, we provide evidence showing that the E64D dimer,
despite retaining the capacity to dimerize, presents different
phenotypic features compared to the WT protein. First, we
found that, in living cells, the E64D dimer forms cytoplasmic
inclusion bodies, and this is accompanied by a reorganization
of the intermediate filament protein vimentin. This prompted
us to use molecular dynamics simulations to verify whether
new or different interactions are predicted to occur with the
E64D dimer, which could explain the different aggregation
propensity compared to WT DJ-1. Past studies have investi-
gated the secondary and quaternary structure of the E64D DJ-
1 [15, 20], but MD for the E64D dimer has not previously
been performed. Our MD results indicate that, although the
E64D mutation is localized far from the dimer interface, it has
a strong effect on both the hydrodynamic and electrostatic
properties of the dimer. Thus, either novel protein–protein
interactions or protein instability caused by the altered surface
charge distribution could be responsible for the formation of
cytoplasmic E64D aggregates in control conditions. It is of
interest to note that, although it is still unclear whether Lewy
bodies are present in individuals with DJ-1 related forms of
PD, nonfunctional aggregated DJ-1 is present in the brain of
patients with neurodegenerative diseases [38], and DJ-1 levels
are strongly increased in the detergent-insoluble fraction from
sporadic PD and dementia with Lewy body brains [39]. Fur-
thermore, DJ-1 forms aggregates in the presence of inorganic
phosphate, levels of which are increased in PD patients [40].
Thus, our observations with E64D DJ-1 could have important
pathogenic ramifications in PD.
We next used BiFC to interrogate the E64D DJ-1 dimer
in oxidative stress conditions. The involvement of DJ-1 in
oxidative stress response is well established in PD and is
strictly linked to the maintenance of the healthy state of
mitochondria within cells. For example, it is well known
that, under oxidative stress conditions, the highly con-
served cysteine residue at position 106 is oxidized to
cystein-sulfinic acid [6], and this oxidation is critical for
DJ-1 protection of mitochondria [4]. Our results clearly
indicate that the E64D dimer does not react to oxidative
stress in the same way as wild-type DJ-1. By testing two
different oxidative stress stimuli, we observed that the WT
DJ-1 dimer is stabilized in oxidative stress conditions,
although this is not the case for the E64D DJ-1 dimer.
We can thus hypothesize that structural/functional changes
in E64D DJ-1 do not allow this mutant to respond nor-
mally in oxidative stress conditions. One possibility is that
altered hydrodynamic/electrostatic properties predicted by
MD for the E64D DJ-1 dimer may perturb its response to
a redox switch. Further experiments will be required to
elucidate the altered properties of E64D DJ-1 in control
and oxidative stress conditions.
In summary, this work has provided new insights into
both DJ-1 dimerization and the E64D DJ-1 mutation in
living cells. We postulate that the E64D mutant, despite
the fact that it appears to dimerize normally, has altered
properties when compared to the WT protein. In addition,
we have strongly validated BiFC as a tool for the study of
DJ-1 dimerization and function. This approach will permit
further analysis of DJ-1 function in living cells and provide
a better understanding of the mechanisms underlying the
pathogenesis of DJ-1 mutations, which cause familial PD.
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